Search

everythinglearnresearchcommunity

for

Search:↓

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Elidel combined with tretinoin is more effective for treating alopecia areata than Elidel alone.

The targeted nanohybrids effectively reduced psoriasis symptoms and improved skin health.

Ritlecitinib may cause serious side effects like blood clots in alopecia areata patients.

Euph E and Euri A from Euphorbia neriifolia help control inflammation and immune response in cells.

Tofacitinib effectively treated a woman's severe symptoms from a rare autoimmune condition.

Rituximab effectively managed a difficult case of juvenile lupus with complications, reducing the need for steroids.

The document's conclusion cannot be provided because the document is not readable or understandable.

Man stopped medications due to sexual side effects, found relief with prostatic artery embolisation.

Avacopan may cause unexpected side effects, so early monitoring is important.

The rash resolved after stopping ponatinib.

Baricitinib was effective in treating severe and very severe alopecia areata after 52 weeks.

A medicine company has recalled a drug because it contained an unlisted blood pressure medication.

Baricitinib helps regrow hair in severe alopecia areata but has side effects like infections and headaches.

The FDA approved a new Pfizer drug for hair loss in teens.

Tofacitinib helped most teenagers in the study regrow hair with mild side effects.

Adding Baricitinib for severe alopecia areata will have a small impact on a health plan's budget.

Ectoin helps prevent cortisone-induced skin problems and supports skin health.

Tofacitinib can be effective in treating hair loss caused by alopecia areata.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

Recombinant Human Annexin A5 may help treat localized scleroderma by reducing skin thickening and inflammation.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Methotrexate caused a rare skin rash in a rheumatoid arthritis patient, which resolved after stopping the drug.

Apremilast was not effective in treating moderate-to-severe alopecia areata.